𝔖 Bobbio Scriptorium

✦ LIBER ✦

Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery

✍ Scribed by Paul R Lichter; David C Musch; Brenda W Gillespie; Kenneth E Guire; Nancy K Janz; Patricia A Wren; M.P.H.Richard P Mills

Book ID: 117327539
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 175 KB
Volume: 108
Category: Article
ISSN: 0161-6420
DOI: 10.1016/s0161-6420(01)00873-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Collaborative Initial Glaucoma Treat

The Collaborative Initial Glaucoma Treatment Study: Interim quality of life findings after initial medical or surgical treatment of glaucoma

✍ Nancy K. Janz; Patricia A. Wren; Paul R. Lichter; David C. Musch; Brenda W. Gill 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 201 KB

The collaborative initial glaucoma treat

The collaborative initial glaucoma treatment study (CIGTS): Reasons for refusing to participate in a surgery vs. medicine trial

✍ David C. Musch; Paul R. Lichter 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Clinical characteristics of newly diagno

Clinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study

✍ Musch, D. C.; Shimizu, T.; Niziol, L. M.; Gillespie, B. W.; Cashwell, L. F.; Lic 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 211 KB

Usefulness of the initial noninvasive im

Usefulness of the initial noninvasive imaging study to predict the adverse outcomes in the medical treatment of acute type a aortic intramural hematoma

✍ J.M Song; H.S Kim; J.K Song 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 30 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB